Vaccine manufacturing plant

UK’s rapid response vaccines manufacturing centre approved

The UK is set to benefit from two fully operational rapid response vaccine manufacturing lines by later this month, after both of the ‘virtual Vaccines Manufacturing and Innovation Centres (VMIC)’ manufacturing lines were approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA).

As part of the national response to develop a Covid-19 vaccine, virtual VMIC will be dedicated to manufacturing a Covid-19 vaccine once one is found to be effective and approved.

Supported by funding from UKRI, the new lines will enable the UK to establish a rapid deployment centre, or ‘virtual VMIC’ while the permanent VMIC facility is being built.

Virtual VMIC will manufacture a vaccine for Covid-19 ahead of the opening of VMIC’s permanent facility, which is also being fast-tracked, next year and will be will be located at the Harwell Science and Innovation Campus in Oxfordshire.

Business Secretary Alok Sharma, said: “We need to be ready to manufacture a vaccine by the millions as quickly as possible if a breakthrough is made. Building up the UK’s capability to produce a COVID-19 vaccine at scale is an essential part of our pandemic response, which is why we have moved so quickly to establish a domestic manufacturing base from scratch. The approval of these two critical manufacturing suites will ensure we have even more capacity to protect the public as soon as a safe and effective COVID-19 vaccine becomes available.”

Andy Jones, Medicines Manufacturing Challenge Director at UKRI, added: “When we provided additional funding to both speed the building of VMIC and provide for a virtual manufacturing centre, we recognised that we needed both innovative approaches to vaccine development and the ability to deliver vaccines at speed and in volume. The approval, by the MHRA, of the manufacturing suites and VMIC equipment will ensure that a vaccine can rapidly be manufactured once an effective vaccine is approved.”

NHE Sept/Oct 21

NHE Sept/Oct 21

Improving care for long-term conditions

Join us in our September/October edition of National Health Executive, as we explore a range of topics impacting and improving the care that we can deliver to patients, the facilities within which we deliver them, and the opportunities in the digital space to accent and evolve our care capabilities

Videos...

View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Festival: Digital Healthcare

The integration of new technology, such as using virtual outpatient appointments instead of face-to-face reviews of patients in the hospital. Adapting the ways in which our NHS workers serve people has been critical in continuing to provide high-quality treatment, a positive patient experience and preventing Covid-19 transmission during the pandemic. Our healthcare sector has the potential to transform the way we continue to provide essential services while also improving patient care. But how easy is the integration of these innovations into routine NHS practice?

On the 28th of October, at the NHE365 Virtual Hospitals & Technology Enabled Care online event, we will be discussing patient flow and experience, reducing waiting times, reducing the patient backlog and increasing technology adoption. Will you be attending? 

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all